MNNGF (Baijin Life Science Holdings) Total Current Assets: $28.44 Mil (As of Sep. 2025)


MNNGF Baijin Life Science Holdings Ltd MNNGF
36 GF Score
Price $0.08
GF Value $0.06
! 4 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Total Current Assets?

Baijin Life Science Holdings MNNGF 36 Total Current Assets is $28.44 Mil as of Sep. 2025. GuruFocus rates MNNGF with a GF Score™ of 36/100 and a GF Value™ of $0.06. The stock has 4 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Baijin Life Science Holdings's total current assets for the quarter that ended in Sep. 2025 was $28.44 Mil.

Baijin Life Science Holdings  (OTCPK:MNNGF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Baijin Life Science Holdings's Liquidation Value for the quarter that ended in Sep. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7.381-15.91+0.75 * 2.467+0.5 * 8.991
=-2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Total Current Assets Related Terms

Baijin Life Science Holdings Total Current Assets Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Total Current Assets Chart

Baijin Life Science Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.17 12.60 15.51 29.20 24.54

Baijin Life Science Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.51 18.96 29.20 28.44 24.54
MNNGF
36GF Score
Baijin Life Science Holdings Ltd MNNGF
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Baijin Life Science Holdings's Total Current Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=6.146+13.97+9.088+0
=29.20

Baijin Life Science Holdings's Total Current Assets for the quarter that ended in Sep. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=7.381+10.638+8.991+1.426
=28.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $28.44 Mil mean?
Baijin Life Science Holdings (MNNGF) has a Total Current Assets of $28.44 Mil as of Sep. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Total Current Assets too high?
Baijin Life Science Holdings' current Total Current Assets is $28.44 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Total Current Assets compare to TPR?
Baijin Life Science Holdings' Total Current Assets of $28.44 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Retail - Cyclical company?
A good Total Current Assets depends on the Retail - Cyclical industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Total Current Assets is $28.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Total Current Assets of $28.44 Mil. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current Total Current Assets is $28.44 Mil. Baijin Life Science Holdings' overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Total Current Assets is $28.44 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.

Key valuation signals for MNNGF:

  • Total Current Assets: $28.44 Mil
  • GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
36GF Score

Get the complete analysis for MNNGF

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.06
GF Value